This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Agence Nationale De Valorisation De La Recherche (Anvar), Aventis Pharma S.a., Centre National De La Recherche Scientifique. Active years: 1983-2009.
Company Filing History:
1 out of 338 
1 out of 377 
1 out of 5,383 
Years Active: 1983-2009
Title: Claude Gerbaud: Innovator in Biosynthesis and Genetic Engineering
Introduction
Claude Gerbaud is a notable inventor based in Gagny, France. He has made significant contributions to the field of biosynthesis and genetic engineering, holding a total of 2 patents. His work focuses on the development of novel antibiotics and the enhancement of antibiotic production.
Latest Patents
Gerbaud's latest patents include groundbreaking inventions related to polypeptides involved in the biosynthesis of spiramycins. One patent details the isolation and identification of novel genes in the biosynthetic pathway for spiramycins. This invention also encompasses a method for producing these polypeptides and the use of these genes to increase the levels of production and purity of spiramycin. Another patent involves hybrid plasmids that serve as vectors for exogenous DNA in yeasts, showcasing his innovative approach to genetic engineering.
Career Highlights
Throughout his career, Claude Gerbaud has worked with prominent organizations such as Aventis Pharma and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to advance his research and contribute to significant scientific developments.
Collaborations
Gerbaud has collaborated with esteemed colleagues, including Henri Heslot and Anne Gondran. These partnerships have further enriched his research and innovation in the field.
Conclusion
Claude Gerbaud's contributions to biosynthesis and genetic engineering highlight his role as a pioneering inventor. His patents and collaborations reflect his commitment to advancing science and technology in the pharmaceutical industry.